The global intelligent prosthetics market is expected to enjoy a valuation of US$ 791.5 million by the end of 2023, and further expand at a CAGR of 6.1% to reach an estimated valuation of US$ 1,437.6 million by 2033. According to a recent study, lower extremity prosthetics by-products led the market with a share of about 64.4% in 2022.
Intelligent prosthetics are predicted to interface with the human nervous system and brain to improve movement precision and comfort. The bridge between the two is joined via technology and artificial intelligence. Also, this is extensively used in upper extremity prosthetics consisting of hand, elbow, and shoulder and lower extremity prosthetics consisting of foot & ankle, knee, and hip.
Ongoing research and development on artificial intelligence (AI) and machine learning are technologically incorporated into the prosthetic and orthotic business, which has been beneficial for people with disabilities. Healthcare professionals are developing less invasive and advanced prosthetics using computer-aided design (CAD) software to enhance the products.
Using this software aids in designing and analyzing the product through 3-D graphics, providing the precision and efficiency needed for prosthetics. For instance,
Attributes | Key Insights |
---|---|
Intelligent Prosthetics Market Value 2022 | US$ 747.4 million |
Estimated Market Value 2023 | US$ 791.5 million |
Projected Market Value 2033 | US$ 1,437.6 million |
CAGR (2023 to 2033) | 6.1 % |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per Future Market Insights (FMI), the global orthopedic prosthetics market was valued at more than US$ 2.1 billion out of which intelligent prosthetics held 33.7% of the total value share in 2022. Rising surgical procedures and the cost-effectiveness of prosthetics are the primary factors stimulating the growth in the market.
Leading producers of rehabilitation tools have used the neural network concept to simulate a variety of morphological and biomechanical functions of the body's missing parts. Further, advancements in technologies such as a bionic limb, mind or thought control prostheses, and exoskeletons are introduced by integrating electronic circuitry, USB-C rechargeable, software, robotic-assisted, and electron beam melting (EBM) technology. This has had a revolutionary impact on the field of rehabilitation.
The use of robotics and artificial intelligence has a significant impact on gaining independent mobility and improving the quality of life for people with disabilities (PwDs). Further, modern three-dimensional(3D) printing technology is aiding intelligent prosthetics to be widely available and affordable, fueling growth.
The rising incidence of diseases such as critical limb ischemia (CLI), which severely damages the extremities of the limbs is another factor necessitating the demand in the market. Subsequently, diabetes and sedentary lifestyles are all contributing to an increase in CLI, which usually results in limb paralysis.
The need for intelligent prosthetics is anticipated to surge due to the growing demand for controlled precision. This is becoming the essential criterion in the field of smart prosthetics.
The patient wearing the prosthesis can make small actions like picking up a dropped object or keeping fingers together owing to regenerative peripheral nerve interface and machine learning algorithms. Backed by these aforementioned factors, the global intelligent prosthetics market is expected to thrive at a CAGR of 6.1% during the forecast period.
Rising Cases of Amputation Due to Trauma Injuries and Cancer Boosting Adoption
Traumatic injuries such as third-degree burns and amputations due to cancer are surging across the globe. This is expected to boost the demand for intelligent prosthetics. The market for intelligent prosthetics is expected to witness a spike over the forecast period due to the rising prevalence of peripheral artery disease, amputations, and bone disorders.
In 2017, Acta Orthopaedica ET Traumatologica Turcicac conducted a study in which they analyzed that during the past 20 years, the rate of amputation caused due to trauma and cancer has decreased by 50%. While, the rate of amputation due to diabetes and peripheral artery disease is escalating at a notable pace, which is driving the demand for intelligent prosthetics.
Better and high-throughput prostheses, including upper- and lower-extremity prosthetics, are gaining immense traction over the past half-decade. To assure safety and quality, hospitals, prosthetic clinics, and rehabilitation facilities are aiming for licensed and patented prosthetics. Hence, manufacturers are focusing on developing their technology. This technology can track patient movement, propose improvements, and directly forward it to the surgeons for better assistance and interaction between end-user and customers. This is expected to provide a boost to sales in the market.
High Cost of AI Prosthetics and Risk of Data Theft to Put Manufacturers in a Pickle
The intelligent prosthetics industry is likely to be hampered by the high cost of these devices and the rigorous regulatory environment. Further, the high cost of intelligent prosthetics is a significant barrier to their widespread use among amputees, especially in emerging economies.
Manufacturers are facing difficulty in lowering the price of the product. According to the Archives of Plastic Surgery, the cost of a traditionally made arm prosthesis in 2019 ranged from US$ 4,000 to US$ 75,000.
The incorporation of AI also includes threats related to hacking. According to Kaspersky's cybersecurity research team, several vulnerabilities in the security of the Motorica prosthetic hands system were discovered which may enable a third party to access, modify, steal, or erase the private data of device users.
Significant Rise in Sports Trauma Injuries to Result in High Adoption
Country | The United States |
---|---|
Market Share % (2022) | 34.7% |
The United States dominated the global market with a value share of 34.7% in 2022 and is projected to continue to experience the same growth throughout the forecast period. Due to an increase in trauma and accidental injuries, the market is expected to witness growth through the forecast period.
There has been a significant surge in sports injuries due to a huge rise in physical activities in the United States. In 2019, there were 468,000 accidents related to exercise, accompanied by about 417,000 injuries associated with cycling, and roughly 700,000 injuries related to basketball and football, according to the National Safety Council (NSC).
Several injuries were severe enough to result in amputation or the need for a bionic replacement. Hence, the demand for intelligent prosthetics is predicted to continue to increase in the United States, boosting growth.
Advanced Medical Facilities and Significant Healthcare Infrastructure to Provide a Thrust to the Market
Country | Germany |
---|---|
Market Share % (2022) | 6.9% |
Germany held a market value share of around 6.9% in the global market in 2022, opines FMI. Germany is considered to be a popular destination for medical tourists due to the cost-to-quality proportion of medical treatment. The market for intelligent prostheses is expected to witness healthy growth on the back of increased patient cooperation and a huge supply of qualified healthcare providers.
The Federal Government of Germany claims that as skilled individuals are employed in medical and nursing areas, Germany has a strong healthcare system. Hence, the availability of such facilities and advanced healthcare infrastructure is expected to create lucrative prospects for the market.
Increasing research and development activities and the presence of advanced scientific facilities are driving the demand in the market. Backed by this, key players are eyeing Germany’s market to collaborate in research and develop powerful multifunctional intelligent prosthetics. This is expected to augment the demand in the market.
The Presence of Leading Prosthetic Providers in the United Kingdom to Generate High Profits
Country | The United Kingdom |
---|---|
Value CAGR % (2023 to 2033) | 4.8% |
The United Kingdom is one of the leading manufacturers of intelligent prosthetics as per the study and is predicted to account for 5.4% of revenue in the global market. Growth is underpinned by enhanced healthcare facilities in the country and prominent manufacturers’ presence.
Increasing product development by leading players such as Ottobock, Blatchford, and others in the United Kingdom is facilitating growth in the market. Additionally, these players are providing well-developed and innovative products with the incorporation of advanced technology. For instance,
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Lower extremity prosthetics are expected to present high growth at a CAGR of 5.6% during the forecast period and held a share of 64.4% in 2022. Due to the rising incidence of traumatic injuries caused by road accidents, lower extremity prosthetics are gaining traction.
According to the National Center for Biotechnology Information, around 1.5 million people in the United States undergo lower extremity prosthetics every year. Due to rising cases of diabetes mellitus, neuropathy, peripheral vascular diseases, and other traumatic injuries, the risk of amputation is high for the lower extremities. This is expected to fuel the demand in the segment.
Over 2/5th of Intelligent Prosthetics Sales is to be Concentrated in Prosthetic Clinics
Segment | Prosthetic Clinics |
---|---|
Market Share % (2022) | 43.1% |
Prosthetic clinics held a high market share of 43.1% in 2022, as per FMI. Easy availability and personalized services for patients in a particular area of concern such as prosthetics are driving the growth in the segment.
Prosthetic clinics are specifically built for patients requiring intense cases of amputations and other traumatic injuries. Hence, key players are collaborating with these clinics extensively to gain revenue. On the back of this, the adoption of intelligent prosthetics is predicted to burgeon at a significant pace in prosthetic clinics.
The overall market is expected to be consolidated with several competitors in the intelligent prosthetics market. To meet consumer demand and expand their customer base, the companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.
Instances of Key Developmental Strategies by the Industry Players in the Intelligent Prosthetics Market
Attributes | Details |
---|---|
Estimated Market Value 2023 | US$ 791.5 million |
Projected Market Value 2033 | US$ 1,437.6 million |
CAGR (2023 to 2033) | 6.1 % |
Forecast Period | 2018 to 2022 |
Historical Data Available for | 2023 to 2033 |
Market Analysis | US$ million for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa |
Key Countries Covered | The United States, Canada, Brazil, Mexico, Argentina, the United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, GCC Countries, North Africa, and South Africa |
Key Market Segments Covered | Product, Distribution Channel, and Region |
Key Companies Profiled |
|
The industry is valued at US$ 791.5 million in 2023.
The Intelligent Prosthetics Market is segmented by product, distribution channel, and region.
The hospitals are the key consumer of the Intelligent Prosthetics Market.
The industry is estimated to reach US$ 1,437.6 million by 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Upper Extremity 5.3.2. Lower Extremity 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033 6.3.1. Hospitals 6.3.2. Prosthetic Clinics 6.3.3. Rehabilitation Centre 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Product 8.2.3. By Distribution Channel 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product 8.3.3. By Distribution Channel 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product 9.2.3. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Distribution Channel 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Product 10.2.3. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Distribution Channel 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Product 11.2.3. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Distribution Channel 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Product 12.2.3. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Distribution Channel 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product 13.2.3. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Distribution Channel 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Product 14.2.3. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Distribution Channel 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Product 15.1.2.2. By Distribution Channel 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Product 15.2.2.2. By Distribution Channel 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Product 15.3.2.2. By Distribution Channel 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Product 15.4.2.2. By Distribution Channel 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Product 15.5.2.2. By Distribution Channel 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Product 15.6.2.2. By Distribution Channel 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Product 15.7.2.2. By Distribution Channel 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Product 15.8.2.2. By Distribution Channel 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Product 15.9.2.2. By Distribution Channel 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Product 15.10.2.2. By Distribution Channel 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Product 15.11.2.2. By Distribution Channel 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Product 15.12.2.2. By Distribution Channel 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Product 15.13.2.2. By Distribution Channel 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Product 15.14.2.2. By Distribution Channel 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Product 15.15.2.2. By Distribution Channel 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Product 15.16.2.2. By Distribution Channel 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Product 15.17.2.2. By Distribution Channel 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Product 15.18.2.2. By Distribution Channel 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Product 15.19.2.2. By Distribution Channel 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Product 15.20.2.2. By Distribution Channel 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Product 15.21.2.2. By Distribution Channel 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Product 15.22.2.2. By Distribution Channel 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Product 15.23.2.2. By Distribution Channel 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product 16.3.3. By Distribution Channel 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Sarcos Technology and Robotics Corporation 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Ktwo Healthcare Pvt. Ltd. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Touch Bionics Inc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. HDT Global 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. SynTouch, Inc. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Artificial Limbs & Appliances 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Ottobock 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Ossur Americas 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Blatchford Group 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Manta Product Development 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports